{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:57:40Z","timestamp":1792519060777,"version":"4.5.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81770671"],"award-info":[{"award-number":["No. 81770671"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82090021"],"award-info":[{"award-number":["No. 82090021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Acute oxalate nephropathy (AON) is an uncommon condition that causes acute kidney injury (AKI), characterized by the massive deposition of calcium oxalate crystals in the renal parenchyma. In previous studies, urinary oxalate excretion has been found to be increased in patients with diabetes mellitus (DM). Here, we report a case series of diabetic patients with AKI with biopsy-proven AON, aiming to alert physicians to the potential of AON as a trigger of AKI in diabetic patients in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Cases with pathological diagnosis of AON who presented with AKI clinically and had DM between January 2016 and December 2020 were retrospectively enrolled. Their clinical and pathological manifestations, treatment, and prognosis were collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Six male patients with biopsy-proven AON out of a total of 5,883 native kidney biopsies were identified, aged 58.3 \u00b1 9.1 years at the time of kidney biopsy. Only one patient who had received Roux-en-Y gastric bypass surgery took oxalate-rich food before the onset of the disease. None of them had clinical features of enteric malabsorption. Three patients were currently on renin-angiotensin system inhibitor treatment for hypertension, and 5 of them received non-steroidal anti-inflammatory drugs. Three patients presented with oliguria and 4 patients needed dialysis at the beginning with none requiring dialysis at discharge. Four patients received a course of corticosteroid treatment empirically. Among them, two patients had estimated glomerular filtration rate (eGFR) recovered to over 60 ml\/min\/1.73 m<jats:sup>2<\/jats:sup>, while the other two patients remained with kidney dysfunction at the last follow-up. In two patients without corticosteroid treatment, one patient fully recovered with eGFR over 90 ml\/min\/1.73 m<jats:sup>2<\/jats:sup> and the other patient remained with kidney dysfunction at the last follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>AON might be a rare but potentially trigger of AKI in patients with DM. A kidney biopsy could help physicians to make the correct diagnosis. The proper treatment to alleviate oxalate-induced injury needs to be further studied.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.929880","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:15:33Z","timestamp":1661508933000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Acute oxalate nephropathy: A potential cause of acute kidney injury in diabetes mellitus\u2014A case series from a single center"],"prefix":"10.3389","volume":"9","author":[{"given":"Daorina","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00240-020-01202-w","article-title":"Calcium oxalate crystal deposition in the kidney: Identification, causes and consequences.","volume":"48","author":"Geraghty","year":"2020","journal-title":"Urolithiasis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ekir.2020.06.021","article-title":"Etiologies, clinical features, and outcome of oxalate nephropathy.","volume":"5","author":"Buysschaert","year":"2020","journal-title":"Kidney Int Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.juro.2010.02.007","article-title":"Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers.","volume":"183","author":"Eisner","year":"2010","journal-title":"J Urol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/MNH.0000000000000229","article-title":"Oxalate, inflammasome, and progression of kidney disease.","volume":"25","author":"Ermer","year":"2016","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jamainternmed.2018.7980","article-title":"Association of urinary oxalate excretion with the risk of chronic kidney disease progression.","volume":"179","author":"Waikar","year":"2019","journal-title":"JAMA Intern Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12882-018-1084-1","article-title":"Star fruit nephrotoxicity: A case series and literature review.","volume":"19","author":"Wijayaratne","year":"2018","journal-title":"BMC Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1056\/NEJMra1301564","article-title":"Primary hyperoxaluria.","volume":"369","author":"Cochat","year":"2013","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ekir.2018.07.020","article-title":"Secondary oxalate nephropathy: A systematic review.","volume":"3","author":"Lumlertgul","year":"2018","journal-title":"Kidney Int Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"685204","DOI":"10.1155\/2014\/685204","article-title":"Glyoxylate, a new marker metabolite of type 2 diabetes.","volume":"2014","author":"Nikiforova","year":"2014","journal-title":"J Diabetes Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/MNH.0000000000000515","article-title":"Urinary oxalate as a potential mediator of kidney disease in diabetes mellitus and obesity.","volume":"28","author":"Efe","year":"2019","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.urology.2020.03.023","article-title":"Association of impaired renal function with changes in urinary mineral excretion and stone composition.","volume":"141","author":"Patel","year":"2020","journal-title":"Urology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.amjmed.2013.03.019","article-title":"Oxalate nephropathy due to \u2018juicing\u2019: Case report and review.","volume":"126","author":"Getting","year":"2013","journal-title":"Am J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.krcp.2014.03.003","article-title":"Peanut-induced acute oxalate nephropathy with acute kidney injury.","volume":"33","author":"Park","year":"2014","journal-title":"Kidney Res Clin Pract."},{"key":"B14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/j.ajkd.2017.08.002","article-title":"\u201cGreen smoothie cleanse\u201d causing acute oxalate nephropathy.","volume":"71","author":"Makkapati","year":"2018","journal-title":"Am J Kidney Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e231504","DOI":"10.1136\/bcr-2019-231504","article-title":"Acute oxalate nephropathy due to high vitamin C doses and exocrine pancreatic insufficiency.","volume":"12","author":"Fijen","year":"2019","journal-title":"BMJ Case Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.15171\/jnp.2017.21","article-title":"Chronic dietary oxalate nephropathy after intensive dietary weight loss regimen.","volume":"6","author":"Khneizer","year":"2017","journal-title":"J Nephropathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.ajkd.2006.10.004","article-title":"Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor.","volume":"49","author":"Singh","year":"2007","journal-title":"Am J Kidney Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1053\/j.gastro.2017.01.004","article-title":"Steatorrhea and hyperoxaluria in severely obese patients before and after Roux-en-Y gastric bypass.","volume":"152","author":"Moreland","year":"2017","journal-title":"Gastroenterology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00467-012-2126-8","article-title":"Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn\u2019s disease.","volume":"27","author":"Hueppelshaeuser","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2215\/CJN.00010111","article-title":"Oxalate nephropathy associated with chronic pancreatitis.","volume":"6","author":"Cartery","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/nep.12858","article-title":"Oxalate nephropathy presenting in exocrine pancreatic insufficiency.","volume":"22","author":"Ye","year":"2017","journal-title":"Nephrology (Carlton)."},{"key":"B22","first-page":"496","article-title":"Oxalate nephropathy: A new entity of acute kidney injury in diabetic patients?","volume":"11","author":"Muji","year":"2015","journal-title":"Rev Med Suisse."},{"key":"B23","doi-asserted-by":"publisher","first-page":"819202","DOI":"10.1155\/2012\/819202","article-title":"Glyoxal formation and its role in endogenous oxalate synthesis.","volume":"2012","author":"Lange","year":"2012","journal-title":"Adv Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3390\/nu12092673","article-title":"Dietary oxalate intake and kidney outcomes.","volume":"12","author":"Bargagli","year":"2020","journal-title":"Nutrients."},{"key":"B25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5527\/wjn.v3.i4.122","article-title":"Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.","volume":"3","author":"Glew","year":"2014","journal-title":"World J Nephrol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1056\/NEJMra1601611","article-title":"Crystallopathies.","volume":"374","author":"Mulay","year":"2016","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8641893","DOI":"10.1155\/2018\/8641893","article-title":"Combining acute kidney injury with gastrointestinal pathology: A clue to acute oxalate nephropathy.","volume":"2018","author":"Fox","year":"2018","journal-title":"Case Rep Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.ajkd.2013.09.010","article-title":"Acute oxalate nephropathy associated with Clostridium difficile colitis.","volume":"63","author":"Cohen-Bucay","year":"2014","journal-title":"Am J Kidney Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI63679","article-title":"Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion.","volume":"123","author":"Mulay","year":"2013","journal-title":"J Clin Invest."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.929880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T14:57:26Z","timestamp":1662389846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.929880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":29,"alternative-id":["10.3389\/fmed.2022.929880"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.929880","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"article-number":"929880"}}